A Randomized Controlled Trial Comparing a Treatment Strategy With Levetiracetam and Valproic Acid in Glioma Patients With a First Seizure

Trial Profile

A Randomized Controlled Trial Comparing a Treatment Strategy With Levetiracetam and Valproic Acid in Glioma Patients With a First Seizure

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Levetiracetam (Primary) ; Valproic acid (Primary)
  • Indications Astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
  • Focus Therapeutic Use
  • Acronyms STING
  • Most Recent Events

    • 14 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top